참고문헌
- Bermudez-Morales VH, Gutierrez LX, Alcocer-Gonzalez JM, Burguete A, Madrid-Marina V (2008). Correlation between IL-10 gene expression and HPV infection in cervical cancer: a mechanism for immune response escape. Cancer Invest, 26, 1037-43. https://doi.org/10.1080/07357900802112693
- Bermudez-Morales VH, Peralta-Zaragoza O, Alcocer-Gonzalez JM, Moreno J, Madrid-Marina V (2011). IL-10 expression is regulated by HPV E2 protein in cervical cancer cells. Mol Med Rep, 4, 369-75.
- Bhattacharjee B, Sengupta S (2006). CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology, 354, 280-5. https://doi.org/10.1016/j.virol.2006.06.018
- Blakaj DM, Fernandez-Fuentes N, Chen Z, et al (2009). Evolutionary and biophysical relationships among the papillomavirus E2 proteins. Front Biosci, 14, 900-17.
- Casas L, Galvan SC, Ordonez RM, et al (1999). Asian-American variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas. Int J Cancer, 83, 449-55. https://doi.org/10.1002/(SICI)1097-0215(19991112)83:4<449::AID-IJC3>3.0.CO;2-0
- Chaiwongkot A, Vinokurova S, Pientong C, et al (2013). Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions. Int J Cancer, 132, 2087-94. https://doi.org/10.1002/ijc.27906
- Chen Z, Storthz KA, Shillitoe EJ (1997). Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences. Cancer Res, 57, 1614-9.
- Chopjitt P, Ekalaksananan T, Pientong C, et al (2009). Prevalence of human papillomavirus type 16 and its variants in abnormal squamous cervical cells in Northeast Thailand. Int J Infect Dis, 13, 212-9. https://doi.org/10.1016/j.ijid.2008.06.017
- Cornet I, Gheit T, Franceschi S, et al (2012). Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J Virol, 86, 6855-61. https://doi.org/10.1128/JVI.00483-12
- de Sanjose S, Quint WG, Alemany L, et al (2010). Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol, 11, 1048-56. https://doi.org/10.1016/S1470-2045(10)70230-8
- Demeret C, Yaniv M, Thierry F (1994). The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter. J Virol, 68, 7075-82.
- Doeberitz Mv, Vinokurova S (2009). Host factors in HPV-related carcinogenesis: cellular mechanisms controlling HPV infections. Arch Med Res, 40, 435-42. https://doi.org/10.1016/j.arcmed.2009.06.002
- Gammoh N, Gardiol D, Massimi P, Banks L (2009). The Mdm2 ubiquitin ligase enhances transcriptional activity of human papillomavirus E2. J Virol, 83, 1538-43. https://doi.org/10.1128/JVI.01551-08
- Grm HS, Massimi P, Gammoh N, Banks L (2005). Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein. Oncogene, 24, 5149-64. https://doi.org/10.1038/sj.onc.1208701
- Helfer CM, Wang R, You J (2013). Analysis of the papillomavirus E2 and bromodomain protein Brd4 Interaction using bimolecular fluorescence complementation. PloS One, 8, 77994. https://doi.org/10.1371/journal.pone.0077994
- Jacquin E, Baraquin A, Ramanah R, et al (2013). Methylation of human papillomavirus type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR. J Clin Microbiol, 51, 3207-15. https://doi.org/10.1128/JCM.01106-13
- Kadaja M, Silla T, Ustav E, Ustav M (2009). Papillomavirus DNA replication-from initiation to genomic instability. Virology, 384, 360-8. https://doi.org/10.1016/j.virol.2008.11.032
- Lee D, Kim JW, Kim K, et al (2002). Functional interaction between human papillomavirus type 18 E2 and poly (ADPribose) polymerase 1. Oncogene, 21, 5877-85. https://doi.org/10.1038/sj.onc.1205723
- Moody CA, Laimins LA (2010). Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer, 10, 550-60. https://doi.org/10.1038/nrc2886
- Nagao S, Yoshinouchi M, Miyagi Y, et al (2002). Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J Clin Microbiol, 40, 863-7. https://doi.org/10.1128/JCM.40.3.863-867.2002
- Natphopsuk S, Settheetham-Ishida W, Pientong C, et al (2013). Human papillomavirus genotypes and cervical cancer in northeast Thailand. Asian Pac J Cancer Prev, 14, 6961-4. https://doi.org/10.7314/APJCP.2013.14.11.6961
- Nishimura A, Ono T, Ishimoto A, et al (2000). Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition. J Virol, 74, 3752-60. https://doi.org/10.1128/JVI.74.8.3752-3760.2000
- Oliveira JG, Colf LA, McBride AA (2006). Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc Natl Acad Sci USA, 103, 1047-52. https://doi.org/10.1073/pnas.0507624103
- Pett M, Coleman N (2007). Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol, 212, 356-67. https://doi.org/10.1002/path.2192
- Pientong C, Wongwarissara P, Ekalaksananan T, et al (2013). Association of human papillomavirus type 16 long control region mutation and cervical cancer. Virol J, 10, 30-7. https://doi.org/10.1186/1743-422X-10-30
- Romanczuk H, Thierry F, Howley PM (1990). Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol, 64, 2849-59.
- Shen XH, Liu SH (2013). Human papillomavirus genotypes associated with mucopurulent cervicitis and cervical cancer in Hangzhou, China. Asian Pac J Cancer Prev, 14, 3603-6. https://doi.org/10.7314/APJCP.2013.14.6.3603
- Steger G, Ham J, Lefebvre O, Yaniv M (1995). The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding. EMBO J, 14, 329-40.
- Tan SH, Leong LE, Walker PA, Bernard HU (1994). The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol, 68, 6411-20.
- Veress G, Szarka K, Dong XP, Gergely L, Pfister H (1999). Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol, 80, 1035-43. https://doi.org/10.1099/0022-1317-80-4-1035
- Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
- Wang L, Dai SZ, Chu HJ, Cui HF, Xu XY (2013). Integration sites and genotype distributions of human papillomavirus in cervical intraepithelial neoplasia. Asian Pac J Cancer Prev, 14, 3837-41. https://doi.org/10.7314/APJCP.2013.14.6.3837
- Yamada T, Manos MM, Peto J, et al (1997). Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol, 71, 2463-72.
- Yao JM, Breiding DE, Androphy EJ (1998). Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB. J Virol, 72, 1013-9.
- Zou N, Lin BY, Duan F, et al (2000). The hinge of the human papillomavirus type 11 E2 protein contains major determinants for nuclear localization and nuclear matrix association. J Virol, 74, 3761-70. https://doi.org/10.1128/JVI.74.8.3761-3770.2000
피인용 문헌
- Integration of human papillomavirus 16 in esophageal carcinoma samples vol.12, pp.1, 2017, https://doi.org/10.1186/s13027-017-0164-3
- Intratype variants of the E2 protein from human papillomavirus type 18 induce different gene expression profiles associated with apoptosis and cell proliferation pp.1432-8798, 2019, https://doi.org/10.1007/s00705-018-04124-6